FDA 510(k)

0,9% Natriumchlorid-Injektion, USP BD PosiFlush™ SF Saline Spülspritze

K-Nummer: K231161 · 2023-07-21

AntragstellerBecton, Dickinson and Company

Entscheidungsdatum2023-07-21

ProduktcodeNGT

BeratungsausschussHO

EntscheidungSubstantially Equivalent

Produktübersicht

0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe is the device name listed in this FDA 510(k) record. The listed applicant is Becton, Dickinson and Company. It received FDA 510(k) clearance on 2023-07-21 under 510(k) number K231161. The device is classified under product code NGT. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Häufig gestellte Fragen

What is the 0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe?

0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe is a medical device that received FDA 510(k) clearance on 2023-07-21. The listed applicant is Becton, Dickinson and Company. The 510(k) number is K231161.

When did 0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe receive FDA 510(k) clearance?

0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe received FDA 510(k) clearance on 2023-07-21, under 510(k) number K231161.

Who is the listed applicant for 0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe?

The FDA 510(k) record lists Becton, Dickinson and Company as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for 0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe?

The FDA product code for 0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe is NGT.

Zugehörige klinische Studien

Zugehörige Einträge werden automatisch anhand von Namen, Produktcodes oder anderen Metadaten abgeglichen. Eine Übereinstimmung begründet kein verifiziertes klinisches, wissenschaftliches, unternehmerisches oder regulatorisches Verhältnis; prüfen Sie die verlinkten offiziellen Quellen.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Weitere Einträge mit Becton, Dickinson and Company als Antragsteller

K262163BD BBL Mueller Hinton II Broth (Cation-Adjusted); BD Difco Mueller Hinton Broth K260128BD Preset™ and BD A-Line™ Arterial Blood Collection Syringes K252506BD Vacutainer® Safety-Lok™ Blood Collection Set; BD Vacutainer® Safety-Lok™ Blood Collection Set with Pre-Attached Holder K252378BD® MiniDraw™ Capillary Blood Collection System with BD® MiniDraw™ SST™ Capillary Blood Collection Tube K260184Onclarity™ Self-Collection Kit K252040BD Vacutainer® Plasma Separator Tubes (PST™), BD Vacutainer® Sodium Heparin Blood Collection Tubes

Alle 102 Geräte anzeigen →

Verwandte Geräte (Code: NGT)

K2508840,9 % Natriumchlorid-Injektion, USP, BD PosiFlush™ SP SpritzeBecton, Dickinson and Company K233623Praxiject™ SP 0.9% NaClMedxl, Inc.K231724Flush Syringe (Prefilled 0.9% normal saline solution)Spm Medicare Pvt. , Ltd.K231363Hantech Pre-filled 0.9% Normal Saline Flush Syringes (Models PFS-1003, PFS-1005, PFS-1010)Hantech Medical Device Co., Ltd.K223584Pre-Filled Normal Saline Flush SyringeAnhui Tianyang Pharmaceutical Co., Ltd.K230756TK Pre-Filled Normal Saline Flush SyringeAnhui Tiankang Medical Technology Co., Ltd.

Offizielle Quelle

In der FDA-Datenbank anzeigen →

Daten aus der FDA Open API. Für die aktuellsten und verbindlichen Informationen konsultieren Sie bitte stets den offiziellen Datensatz.